Events

Events Search and Views Navigation

Event Views Navigation

Today

  • EPI2012

    SPH, 5th floor, Conference Room 5140

  • EPI2012

    SPH, 5th floor, Conference Room 5140

  • EPI2012

    SPH, 5th floor, Conference Room 5140

  • Summer Seminar Session 2

    SPH, 5th floor, Conference Room 5140

    The seminar’s focus will be on differences in blood-based biomarker by race/ethnicity, and how representation in study samples and analytic methods may affect our estimates of differences between subgroups. The following articles will be discussed; Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults Impact of racialization on neuroimaging and plasma […]

  • EPI2012

    No class. Independent study to work on final paper.  

  • EPI2012

    SPH, 5th floor, Conference Room 5140

  • EPI2012

    SPH, 5th floor, Conference Room 5140

  • Summer Seminar Session 3

    SPH, 5th floor, Conference Room 5140

    We will be discussing eligibility and recruitment in past and ongoing clinical trials for AD with a focus on implications for clinical care and generating evidence for interventions.    For reference on Active Trials: https://www.nia.nih.gov/research/ongoing-AD-trials Anderson TS, Ayanian JZ, Souza J, Landon BE. Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for […]

  • Summer Writing Retreat

    This 3-day PNA hosted event is a dedicated time to focus on your own work while surrounded by a supportive community of peers. Whether you're drafting, revising, or refining, attendees have uninterrupted time to write alongside colleagues who are available to offer feedback, answer questions, and keep you motivated. For more information regarding sign-ups and […]

  • Summer Seminar Session 4

    SPH, 5th floor, Conference Room 5140

    We will be discussing AD plasma biomarkers in participants with Down syndrome. Many of our discussions in the past few weeks have centered around how comorbidities and enhanced risk may affect the relationship between biomarker and disease. This week, we will take a closer look at a clinical population that has a genetically determined high risk of AD and […]